Lineage Cell Therapeutics In shares owned by Morgan Stanley
Quarter-by-quarter ownership of Lineage Cell Therapeutics In (LCTX) shares owned by Morgan Stanley
from 13F filings
Historical chart of Morgan Stanley investment in Lineage Cell Therapeutics In
Tip: Access up to 7 years of quarterly data
All positions including Lineage Cell Therapeutics In held by Morgan Stanley consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Lineage Cell Therapeutics In by Morgan Stanley
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-03-31 | $678k | 459k | 1.48 |
| 2023-09-30 | $328k | 278k | 1.18 |
| 2023-06-30 | $215k | 152k | 1.41 |
| 2022-12-31 | $154k | 132k | 1.17 |
| 2022-06-30 | $236k | 129k | 1.83 |
| 2022-03-31 | $379k | 244k | 1.55 |
| 2021-06-30 | $368k | 129k | 2.86 |
| 2020-12-31 | $202k | 130k | 1.56 |
| 2020-09-30 | $50k | 53k | 0.94 |
| 2020-06-30 | $74k | 85k | 0.87 |
| 2020-03-31 | $49k | 58k | 0.84 |
| 2019-12-31 | $176k | 197k | 0.89 |
| 2019-09-30 | $76k | 78k | 0.97 |